Is Wegovy a GLP-1 medicine, and does that matter for weight loss?

The biggest misconception: Wegovy creates a new signal your body has never seen

One of the most common misunderstandings about Wegovy is that it introduces some foreign chemical that overrides normal hunger. It does not. Semaglutide is a close analogue of GLP-1, a hormone your intestines already secrete every time you eat. The medicine simply activates the same receptor that natural GLP-1 binds to, it just lasts far longer in the body than the hormone your gut produces, which breaks down within minutes.

That extended duration is the point. A once-weekly injection of semaglutide keeps GLP-1 receptors active across the whole week, sustaining the fullness signals and the slower stomach emptying that a meal-triggered burst of natural GLP-1 can only provide for an hour or two. The result is that many people find they reach their appetite limit much sooner at meals and feel less driven to snack between them. This is not willpower, it is biology, working through a pathway the body already understands. You can read more about how semaglutide works as a GLP-1 medicine in our dedicated explainer.

The STEP 1 clinical trial, published in the New England Journal of Medicine, followed adults with obesity over 68 weeks and found an average body-weight reduction of around 15% at the 2.4 mg maintenance dose. Those results reflect the GLP-1 mechanism doing what it is designed to do, not a metabolic shortcut, but a sustained change in appetite signalling alongside a reduced-calorie diet and increased activity.

What Wegovy's GLP-1 action does, and what it does not do

The GLP-1 receptor sits in several places: the gut, the pancreas, and areas of the brain involved in appetite regulation. When semaglutide binds to those receptors, three things happen. Gastric emptying slows, so food stays in the stomach longer and fullness arrives faster. The pancreas adjusts insulin and glucagon release in a glucose-dependent way, which is why semaglutide is classified as a GLP-1 drug and is also used in type 2 diabetes. And the hypothalamus receives reduced hunger signals, which is where the meaningful effect on food intake comes from.

What semaglutide does not do is burn fat directly, block calorie absorption, or act as a stimulant. It does not work without the lifestyle component; the clinical trials paired it with dietary advice and activity goals throughout. The NHS semaglutide medicines page explains this clearly, Wegovy is an adjunct to a reduced-calorie diet and increased physical activity, not a replacement for them.

It is also worth knowing that GLP-1 and semaglutide are related but not interchangeable terms, and Tirzepatide, the active ingredient in Mounjaro, adds a second mechanism by also activating GIP receptors, which is one reason the two medicines are often compared. If you are weighing up those options, our weight-loss treatment overview sets out both.

GLP-1, prescription status, and what that means practically

Because Wegovy is a prescription-only medicine, accessing it legally in the UK means a prescriber must assess your individual circumstances first. That is not a bureaucratic hurdle, the GLP-1 mechanism brings genuine clinical considerations. Semaglutide slows gastric emptying, which can affect how oral medications are absorbed, including the contraceptive pill. Anyone on oral contraceptives starting Wegovy should talk to their prescriber about this specifically. The NHS England guidance on weight-management injections covers this and other practical points, including advice around surgery and HRT.

Common side effects follow directly from the GLP-1 mechanism: nausea, constipation, diarrhoea, and indigestion are the most frequently reported, particularly in the early weeks or after a dose increase. They tend to settle. More serious but rare effects, including pancreatitis, mean that severe persistent stomach pain that radiates to the back warrants urgent medical attention.

Wegovy arrives as a pre-filled weekly injection pen, refrigerated in transit and delivered in plain packaging, the kind of plain brown box with a DPD tracking notification that tells you nothing about what is inside. A clinical review precedes every prescription; it is what makes the difference between a medicine used safely and one that causes harm. If you are considering treatment, understanding exactly how Wegovy's GLP-1 activity works is a useful first step before speaking to a prescriber.

For context on what private treatment through a GPhC-registered pharmacy typically involves in terms of cost, our Wegovy pricing guide explains what to expect and what a legitimate price should include. When you are ready to talk to a prescriber about whether Wegovy is right for you, you can check your eligibility through a free consultation with our clinical team.